Does a diabetes drug also work in chronic kidney disease without diabetes
The PDB structures with the following accession codes 2WCI, 3L4N, 3D4M, 3D5J, 2M80, 2WUL, 2WOU, 1MEK, 1B4Q and 4FIW were used in this work
Foods contribute to daily fluid intake under normal circumstances, so dramatic dietary reduction without compensatory increased beverage consumption can affect hydration status
A 26-week clinical study comparing the effectiveness of liraglutide (1.8 mg once-daily) with exenatide (10 g twice-daily) indicates that patients treated with liraglutide had significantly greater reduction in HbA1c levels as well as significantly greater reduction in fasting plasma glucose levels as compared to patients treated with exenatide (Buse et al., 2009)
For example, the LEADER trial showed that Liraglutide significantly reduced the risk of major adverse cardiovascular events (MACE) by 13% and cardiovascular death by 22% in comparison to placebo